$2.290
-0.030 (-1.29%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
LXRX Prediction & Forecast by Similar Chart Analysis
Alphio's LXRX stock price prediction model matches the current Lexicon Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.31 (+1.09%). The 1-week path is $2.25 (-1.55%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Lexicon Pharmaceuticals Inc Stock?
Lexicon Pharmaceuticals (LXRX) is a good buy right now due to its recent milestone payment of $10 million from Novo Nordisk, contributing to a total of $75 million in milestone payments, indicating strong collaboration and growth potential. The current price of $2.29 is significantly below the analyst price target of $3.10, suggesting a potential upside of 35.4%. Additionally, the company has shown a remarkable year-to-date change of +100.88%, reflecting strong investor interest and optimism about its future prospects. However, the main risk is the high negative net income reported for Q2 2026 at -31.77 million USD, which highlights ongoing financial challenges that investors should monitor closely.
LXRX stock price ended at $2.29 on Friday, after losing -1.29%
Lexicon Pharmaceuticals Inc (LXRX) last closed at $2.29, losing -1.29%. These facts feed the 1-day and 1-week LXRX price prediction above.
Analyst Consensus
Lexicon Pharmaceuticals Inc (LXRX): 4 buy, 3 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Lexicon Pharmaceuticals Inc (LXRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches LXRX, ranked by similarity.
Seasonality analysis for LXRX
Historically the probability of a positive August return for LXRX is 95.24%. July offers the highest probability of a positive month at 100.00%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for LXRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.26 | $1.72 | $2.36 | -24.75% |
| Sep 2026 | $0.65 | $1.39 | $1.49 | -39.36% |
| Oct 2026 | $0.75 | $1.48 | $1.77 | -35.46% |
| Nov 2026 | $1.58 | $2.02 | $2.71 | -11.97% |
| Dec 2026 | $1.46 | $1.69 | $2.20 | -26.11% |
In 2026, Lexicon Pharmaceuticals Inc (LXRX) is projected to range from $0.65 to $2.71.
Lexicon Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Lexicon Pharmaceuticals Inc is projected to average $1.72, with a low of $1.26 and high of $2.36.
In Sep 2026, Lexicon Pharmaceuticals Inc is projected to average $1.39, with a low of $0.65 and high of $1.49.
In Oct 2026, Lexicon Pharmaceuticals Inc is projected to average $1.48, with a low of $0.75 and high of $1.77.
In Nov 2026, Lexicon Pharmaceuticals Inc is projected to average $2.02, with a low of $1.58 and high of $2.71.
In Dec 2026, Lexicon Pharmaceuticals Inc is projected to average $1.69, with a low of $1.46 and high of $2.20.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.